Processa Pharmaceuticals (NASDAQ:PCSA) stock rallied 25% in morning trading Friday after the company said it plans to expand development of NGC-Cap into breast cancer to provide a “more efficient” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results